NovaBridge Biosciences (NBP) Return on Assets (2020 - 2025)
NovaBridge Biosciences (NBP) reported Return on Assets of 0.0% for Q4 2025, little changed year-over-year from 0.0% in Q4 2024, and down 59.5% quarter-over-quarter from 0.0% in Q3 2025.
NovaBridge Biosciences (NBP) Return on Assets (2020 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 6 years of Return on Assets data on file, last reported at 0.0% in Q4 2025.
- Return on Assets for Q4 2025 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY), and the FY2024 annual result was 0.0%, changed 0.0% from the prior year.
- Return on Assets declined to 0.0% in Q4 2025 per NBP's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q3 2024 and troughed at 0.0% in Q4 2025.
- A 5-year average of 0.0% and a median of 0.0% in 2021 frame the typical range for Return on Assets.
- On a YoY basis, Return on Assets climbed as much as 0 bps in 2021 and fell as far as 0 bps in 2021.
- A 5-year view of Return on Assets shows it stood at 0.0% in 2021, then jumped by 131 bps to 0.0% in 2022, then tumbled by 132 bps to 0.0% in 2023, then jumped by 275 bps to 0.0% in 2024, then sank by 392 bps to 0.0% in 2025.
- Business Quant data shows NBP's Return on Assets at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -0.01% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -0.01% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -0.01% |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |